Sofinnova Investments, Inc. Cti Biopharma Corp Transaction History

Sofinnova Investments, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$4.2 - $6.01 $7.61 Million - $10.9 Million	-1,811,985 Reduced 39.34%	2,794,542 $11.7 Million
Q4 2022 Feb 13, 2023	BUY	$4.45 - $6.17 $4.42 Million - $6.13 Million	994,151 Added 27.52%	4,606,527 $27.7 Million
Q3 2022 Nov 08, 2022	BUY	$5.36 - $7.43 $4.87 Million - $6.75 Million	907,866 Added 33.57%	3,612,376 $21 Million
Q2 2022 Aug 15, 2022	BUY	$3.55 - $6.27 $2.67 Million - $4.71 Million	751,819 Added 38.5%	2,704,510 $16.1 Million
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $3.71 Million - $10.2 Million	1,952,691 New	1,952,691 $9.12 Million

Q4 2021 Feb 14, 2022	SELL	$1.44 - $2.86 $2.99 Million - $5.93 Million	-2,074,714 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.25 - $3.18 $4.28 Million - $6.05 Million	1,903,095 Added 1108.91%	2,074,714 $6.12 Million
Q2 2021 Aug 16, 2021	BUY	$2.16 - $2.62 $370,697 - $449,641	171,619 New	171,619 $429,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.